Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-059554
Filing Date
2015-08-13
Accepted
2015-08-13 16:00:50
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-15924_110q.htm 10-Q 927347
2 EX-31.1 a15-15924_1ex31d1.htm EX-31.1 12206
3 EX-31.2 a15-15924_1ex31d2.htm EX-31.2 12173
4 EX-32.1 a15-15924_1ex32d1.htm EX-32.1 6569
  Complete submission text file 0001104659-15-059554.txt   4096619

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20150630.xml EX-101.INS 767882
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20150630.xsd EX-101.SCH 33307
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20150630_cal.xml EX-101.CAL 38468
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20150630_lab.xml EX-101.LAB 341222
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20150630_pre.xml EX-101.PRE 252000
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20150630_def.xml EX-101.DEF 146891
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 151050617
SIC: 2834 Pharmaceutical Preparations